drugset / Trial / NCT01579110

Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.

NCT01579110

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Levamisole plus prednisone can further improve the efficacy,extend the remission duration and reduce the dosage of prednisone for newly diagnosed warm antibody autoimmune hemolytic anemia.

Timeline

Start
2012-04
Primary completion
2015-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Levamisole Small molecule 2.5 mg/kg
Comparator Prednisone Other / unclassified 1 mg/kg